Johanna Mylet

Senior Vice President, Finance, Poseida Therapeutics, Inc.

Companies

Poseida Therapeutics, Inc.Chief financial officer Nov 2, 2021 to Jan 8, 2025¹
Poseida Therapeutics, Inc.Senior Vice President, Finance Jul 9, 2020 to Feb 5, 2021²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 8, 2025U 254,852 shares of Poseida Therapeutics, Inc.³
Mar 1, 2024Shares withheld for tax 18,091 shares at $4.13 of Poseida Therapeutics, Inc.⁴
Mar 1, 2024Granted 80,743 shares of Poseida Therapeutics, Inc.⁴
Mar 1, 2023Shares withheld for tax 4,323 shares at $5.35 of Poseida Therapeutics, Inc.⁵
Mar 1, 2023Granted 92,772 shares of Poseida Therapeutics, Inc.⁵
Mar 1, 2022Granted 50,000 shares of Poseida Therapeutics, Inc.⁶
Dec 21, 2021Exercised options 3,100 shares at $1.93 of Poseida Therapeutics, Inc.⁷
Dec 21, 2021Exercised options 2,616 shares at $1.17 of Poseida Therapeutics, Inc.⁷

The numbers on this page point here. Each one links to the record it came from.